19:08 , Mar 23, 2017 |  BC Innovations  |  Finance

Biology on the mind

Less than a year and a half after its launch, the Dementia Discovery Fund has spawned four new companies and invested almost 10% of the roughly $100 million it raised in 2015. With a goal...
07:00 , Sep 16, 2013 |  BioCentury  |  Emerging Company Profile

Cardeus: Microglia blockade

Astellas Pharma Inc. spinout Cardeus Pharmaceuticals Inc. 's COX-1 inhibitor tamps down neuroinflammation in the brain and could be synergistic with other treatments to keep dementia associated with diseases like Parkinson's in check. Activation of...
07:00 , Apr 4, 2011 |  BC Week In Review  |  Company News

Cardeus, Astellas deal

Cardeus was founded with seed financing from Mitsui & Co. Global Investment. Astellas Venture also plans to invest in the newco. Further terms were not disclosed. Cardeus Pharmaceuticals Inc. , Menlo Park, Calif.   Astellas...
00:10 , Apr 1, 2011 |  BC Extra  |  Company News

Newco Cardeus in-licenses Astellas compounds

Astellas Pharma Inc. (Tokyo:4503) granted new company Cardeus Pharmaceuticals Inc. (Menlo Park, Calif.) exclusive, worldwide rights, excluding Japan, to three compounds for undisclosed indications. The compounds include: YM758, an undisclosed ion channel protein inhibitor; ASP6537,...